Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $41.13, but opened at $44.00. Ascentage Pharma Group International shares last traded at $44.00, with a volume of 496 shares.
Ascentage Pharma Group International Price Performance
The company has a 50 day moving average price of $41.04 and a two-hundred day moving average price of $29.44. The company has a quick ratio of 1.53, a current ratio of 1.54 and a debt-to-equity ratio of 1.31.
Institutional Trading of Ascentage Pharma Group International
Several large investors have recently modified their holdings of AAPG. Chevy Chase Trust Holdings LLC bought a new stake in shares of Ascentage Pharma Group International in the second quarter worth $227,000. Hsbc Holdings PLC bought a new stake in shares of Ascentage Pharma Group International in the second quarter worth $391,000. Tema Etfs LLC bought a new stake in shares of Ascentage Pharma Group International in the second quarter worth $610,000. Finally, Monashee Investment Management LLC bought a new stake in Ascentage Pharma Group International during the first quarter valued at about $3,511,000.
About Ascentage Pharma Group International
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Stories
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
